Clinical Scorecard: VA DOD Updates Asthma Framework
At a Glance
| Category | Detail |
|---|---|
| Condition | Asthma |
| Key Mechanisms | Shift from symptom-driven reliever therapy to anti-inflammatory strategies, emphasizing inhaled corticosteroids (ICS) and rapid-onset long-acting beta-agonists (LABA). |
| Target Population | Patients older than 5 years with chronic asthma. |
| Care Setting | Primary care |
Key Highlights
- Single-device maintenance and reliever therapy (SMART) reduces severe asthma exacerbations by about one-third.
- Updated guidelines recommend ICS-containing reliever strategies over SABA-only therapy.
- Emphasis on managing comorbidities like obesity and gastroesophageal reflux disease to improve asthma control.
- Step-down therapy is appropriate after stable control for at least 3 months, but ICS should not be discontinued.
- Routine spirometry for stable asthma monitoring is not recommended.
Guideline-Based Recommendations
Diagnosis
- Focus on chronic asthma management in primary care settings.
Management
- Use ICS for asthma control in all patients, regardless of symptom frequency.
- Consider ICS combined with rapid-onset LABA for patients aged 12 years or older.
Monitoring & Follow-up
- Avoid routine spirometry for monitoring stable asthma.
Risks
- Increased asthma-related morbidity and mortality linked to insufficient ICS use.
Patient & Prescribing Data
Adults with asthma, particularly those with comorbid conditions.
Weight loss and treatment of gastroesophageal reflux disease can improve asthma control.
Clinical Best Practices
- Develop a written asthma action plan to enhance control and quality of life.
- Avoid routine use of indoor air filtration devices due to limited evidence of benefit.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
